Ruxolitinib for the treatment of myelofibrosis: its clinical potential

Alen Ostojic1, Radovan Vrhovac1, Srdan Verstovsek21Division of Hematology, Department of Internal Medicine, University Hospital Center Zagreb, Zagreb, Croatia; 2Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX, USAAbstract: Ruxolitinib is an orally bioavailable, se...

Full description

Saved in:
Bibliographic Details
Main Authors: Ostojic A (Author), Vrhovac R (Author), Verstovsek S (Author)
Format: Book
Published: Dove Medical Press, 2012-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available